Hepatic granulomas following liver transplantation: A retrospective survey, and analysis of possible microbiological

Anisoara Iordache1, Kurt Fuursted2, Charlotte Vestrup Rift1

  • 1Department of Pathology, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark.

PubMed
Abstract

Insights

Liver granulomas are common in liver transplant biopsies, often appearing in the first six months post-transplant, particularly in patients with autoimmune liver disease and acute cellular rejection. No infectious agents or distinct microbiome were identified as causes.

Area of Science:

  • Hepatology
  • Transplantation Immunology
  • Pathology

Background:

  • Liver granulomas present diagnostic challenges, with limited data on their prevalence and causes in liver transplant recipients.
  • Understanding granuloma etiology in this population is crucial for optimizing patient management.

Approach:

  • Examined liver biopsies from 217 liver transplant patients between 2011 and 2017.
  • Assessed histomorphological features, clinicopathological data, and utilized next-generation sequencing (NGS) for pathogen detection in granuloma-containing biopsies.

Key Points:

  • Granulomas were identified in 45.2% of patients (32.8% of biopsies), predominantly as parenchymal epithelioid granulomas.
  • Granulomas frequently co-occurred with acute cellular rejection (ACR) and were common in patients transplanted for autoimmune-related liver disease (AILD).
  • The highest incidence of granulomas was observed within the first six months post-transplantation.

Conclusions:

  • Liver allograft biopsies frequently show granulomas, mainly in the parenchyma, especially in the early post-transplant phase.
  • Granulomas are associated with AILD and ACR episodes, but no specific infectious agent or consistent microbiome was identified.
  • The findings highlight the non-infectious nature of most granulomas in liver transplant recipients.